NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

At entry to the study 43 patients (61%) were using Novopen ® 3 to administer their insulin, 22 (31%) were using syringes, and five (7%) had used a combination of Novopen ® 3 and syringes.

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.